CD8A and mesenchymal cell neoplasm: EMT broadly up-regulates multiple immune checkpoint and inflammatory molecules to produce CD8+ T cell exhaustion, highlighting multiple potential mechanisms for the development of therapeutic resistance to immune therapy in mesenchymal tumors.